|
|
Central nervous system agent
|
|
Antipsychotic agent
|
|
Psychotic disorders.
|
|
Usual is 50 mg/kg/day in divided doses every 3 hours.
|
|
Category NR
|
|
Low blood count, nausea, abdominal pain, vomiting, bitter taste, Diarrhea, dizziness, weakness, mental Depression, Seizures, EEG changes, ECG changes, Nasal Congestion, dry mough, inhibited ejaculation, Aplastic Anemia, cholestatic jandice, elevated protein-bound iodine, allergic reactions, gastritis.
|
Pregnancy Risk Categories defined:
A: Studies in pregnant women failed to show a risk to the fetus in the first
trimester - with no evidence of risk in the later trimesters.
B: Animals studies indicate no adverse effect to the fetus, but there are no adequate,
clinical studies in pregnant women.
C: Animal studies have shown an adverse effect on the fetus, but there are no adequate,
clinical studies in humans. Despite potential risks, the drug may be useful in pregnant
women.
D: There is evidence of risk to the human fetus, but the potential benefits of use in
pregnant women may be acceptable, despite potential risks.
X: Studies in animals or humans show fetal abnormalities, or adverse reaction reports
indicate evidence of fetal risk. Warning: the risks involved clearly outweigh any
potential benefit from using the drug in pregnant women, regardless of trimester.
NR: Not rated (i.e., no information available at this time as to the potential
risks or benefits).
|
| | |
If you want your friend to read or know about this article, Click here
|
|
|